Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eloisa Yuste

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of General Virology|December 26, 2001
Frequency-dependent selection in human immunodeficiency virus type 1Eloisa Yuste, Andrés Moya, Cecilio López-Galíndez
Vaccines|October 26, 2024
Antiretroviral Therapy with Ritonavir-Boosted Atazanavir- and Lopinavir-Containing Regimens Correlates with Diminished HIV-1 NeutralizationEloisa Yuste, Horacio Gil, Felipe Garcia, et al.
Beilstein Journal of Organic Chemistry|July 4, 2014
Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugsFabrizio Chiodo, Marco Marradi, Javier Calvo, et al.
Current HIV Research|March 10, 2016
Antibody-Based Preventive and Therapeutic Strategies Against HIVAmanda Fabra-Garcia, Carolina Beltran, Victor Sanchez-Merino, et al.
Vaccines|April 23, 2022
Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 EnvelopeDiana Aguado-Garcia, Alex Olvera, Christian Brander, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 28, 2016
Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activityMaría José Gómara, Ignacio Pérez-Pomeda, José María Gatell, et al.
Plos One|August 11, 2015
HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing ActivityMaria Pernas, Victor Sanchez-Merino, Concepcion Casado, et al.
Nature Medicine|May 19, 2009
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysPhilip R Johnson, Bruce C Schnepp, Jianchao Zhang, et al.
Journal of Virology|September 6, 2013
Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulationsCarolina B Ferreira, Alberto Merino-Mansilla, Anuska Llano, et al.
Vaccines|January 26, 2024
The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ RatiosVictor Sanchez-Merino, Miguel Martin-Serrano, Manuela Beltran, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of General Virology|December 26, 2001
Frequency-dependent selection in human immunodeficiency virus type 1Eloisa Yuste, Andrés Moya, Cecilio López-Galíndez
Vaccines|October 26, 2024
Antiretroviral Therapy with Ritonavir-Boosted Atazanavir- and Lopinavir-Containing Regimens Correlates with Diminished HIV-1 NeutralizationEloisa Yuste, Horacio Gil, Felipe Garcia, et al.
Beilstein Journal of Organic Chemistry|July 4, 2014
Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugsFabrizio Chiodo, Marco Marradi, Javier Calvo, et al.
Current HIV Research|March 10, 2016
Antibody-Based Preventive and Therapeutic Strategies Against HIVAmanda Fabra-Garcia, Carolina Beltran, Victor Sanchez-Merino, et al.
Vaccines|April 23, 2022
Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 EnvelopeDiana Aguado-Garcia, Alex Olvera, Christian Brander, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 28, 2016
Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activityMaría José Gómara, Ignacio Pérez-Pomeda, José María Gatell, et al.
Plos One|August 11, 2015
HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing ActivityMaria Pernas, Victor Sanchez-Merino, Concepcion Casado, et al.
Nature Medicine|May 19, 2009
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysPhilip R Johnson, Bruce C Schnepp, Jianchao Zhang, et al.
Journal of Virology|September 6, 2013
Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulationsCarolina B Ferreira, Alberto Merino-Mansilla, Anuska Llano, et al.
Vaccines|January 26, 2024
The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ RatiosVictor Sanchez-Merino, Miguel Martin-Serrano, Manuela Beltran, et al.
Pageof 2